LiMMTherapeuticsis a biopharmaceutical company focused on the development of therapeutic products for the treatment of inflammatory, infectious, and metabolic diseases.The company has a research center in Portugal with supporting ties with one of the most relevant European health foundations.
- Pioneering discoveries on the regulation on Innate Lymphoid Cells (ILCs) by neuronal cell derived signaling
- Impressive team led by Henrique VeigaFernandes lab (Paul Allen Distinguished Investigator at Champalimaud Foundation in Portugal
- Biopharmaceutical company developing first-in-class therapeutic products –NRILs: neuronal reprogrammers of innate lymphocytes –to preserve health and treat inflammatory, infectious and metabolic diseases
- Exciting sustainable impact potential

Investment date: 2021